Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.200
+0.280 (7.14%)
At close: Jun 26, 2026, 4:00 PM EDT
4.060
-0.140 (-3.33%)
After-hours: Jun 26, 2026, 6:30 PM EDT
Camp4 Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Camp4 Therapeutics stock have an average target of 8.36, with a low estimate of 6.50 and a high estimate of 12. The average target predicts an increase of 99.05% from the current stock price of 4.20.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Camp4 Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 25, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Upgrades $9 | Buy | Upgrades | $9 | +114.29% | Jun 23, 2026 |
| Chardan Capital | Chardan Capital | Buy Initiates $6.5 | Buy | Initiates | $6.5 | +54.76% | Jun 10, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +185.71% | May 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +90.48% | May 8, 2026 |
Financial Forecast
Revenue This Year
6.27M
from 3.50M
Increased by 79.11%
Revenue Next Year
6.82M
from 6.27M
Increased by 8.79%
EPS This Year
-0.79
from -1.65
EPS Next Year
-0.78
from -0.79
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.6M | 9.2M | |
| Avg | 6.3M | 6.8M | |
| Low | 1.3M | 2.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 174.4% | 46.8% | |
| Avg | 79.1% | 8.8% | |
| Low | -63.0% | -60.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.68 | -0.49 | |
| Avg | -0.79 | -0.78 | |
| Low | -0.97 | -0.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.